Get free PhD updates, every week | SIGN UP NOW Get free PhD updates, every week | SIGN UP NOW

We have 16 Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Bradford

Discipline

Discipline

Medicine

Location

Location

Bradford  United Kingdom

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Bradford

We have 16 Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Bradford

A PhD in Pharmacy gives you the chance to lead your own research project that will further our current understanding of pharmaceuticals. Whether you are researching medicines tailored to an ageing population, optimising existing drugs through changes in dosage, or looking at the causes of neurological and psychiatric diseases, you will be aiming to improve the lives of millions of people around the globe.

What’s it like to study a PhD in Pharmacy?

Doing a PhD in Pharmacy, you will become proficient in the skills necessary to contribute to a research portfolio which spans pharmacy practice, pharmaceutics, and drug discovery. You will spend time reading around your research area and gain inspiration for methods to improve your experimental work. Your main aim will be to exploit the current advances in pharmaceutical practices and biological sciences.

Some typical research topics in Pharmacy include:

  • nanomedicine and biotherapeutics
  • developing nanomaterials for drug delivery
  • infection and antimicrobial resistance
  • pharmacy practice

Typical Pharmacy PhD research projects take between three and four years to complete. During a standard PhD day, you will either be in the laboratory performing, preparing, or planning experiments, (if your project is laboratory based), researching pharmacy practice and policy, writing up sections of your thesis, and chatting to your colleagues and supervisor about your current and upcoming work.

To be awarded your PhD, you must submit a thesis of about 60,000 words and defend this during your viva exam.

PhD in Pharmacy entry requirements

The entry requirements for a typical PhD in Pharmacy usually involves a Bachelors and a Masters degree in a related subject. You will also need to submit a compelling research proposal detailing your study plans. You may also need some professional experience in Pharmacy, depending on the programme.

PhD in Pharmacy funding options

In the UK, PhDs in Pharmacy are funded by the Medical Research Council (MRC), which provides a tuition fee waiver and a living cost stipend. Depending on the programme, you may submit your own research proposal before being considered for funding or apply for a project that already has funding attached. 

It is also possible to apply for a PhD loan to help with the costs of a doctorate in Pharmacy (although this cannot be combined with Research Council funding). Other options for financial support include university scholarships, graduate teaching assistantships and charities.

If you are considering a part-time PhD in Pharmacy, it may also be worth asking your employer if they are happy to sponsor you. 

PhD in Pharmacy careers

On completion of your PhD, you may go into a research role at a university or pharmaceutical company, or you may find a career in regulatory affairs, the NHS (National Health Service) or scientific publishing, drug licensing or clinical trial research.

read more
PhD saved successfully

Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Therapeutic resolution of coronavirus (COVID-19) diseases by natural products

  Research Group: Pharmacology and Experimental Therapeutics
Coronavirus now labelled as Covid-19 has become a global pandemic affecting around 200 countries. Currently neither any cure nor any vaccine for Covid-19 has been established. Read more

Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

ERK5 MAPK signalling in Alzheimer’s disease

  Research Group: Pharmacology and Experimental Therapeutics
Neurodegenerative diseases have devastating effects on individuals’ lives and our society, with no effective treatments available. Read more

Development of a personalized therapy for pulmonary arterial hypertension (PAH)

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Targeting the MAPK scaffold protein KSR1 for the treatment of prostate cancer

  Research Group: Institute of Cancer Therapeutics
Prostate cancer is one of the leading causes of male cancer deaths. It arises when individual cells escape their normal growth control mechanisms and proliferate in an uncontrolled fashion. Read more

Investigation into the in-vitro lung deposition of liposomal formulations of the dual fixed-dose combination inhaler

  Research Group: Medicines Development and Pharmaceutical Sciences
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are diseases associated with the airflow in the lungs (WHO, 2013). Inhalation is the most effective route of administration for treating asthma and COPD (Labiris and Dolovich, 2003). Read more

Integrated omics approach to psychiatric disorders

  Research Group: Chemistry and Biosciences
In psychiatry, the selection of antipsychotics and antidepressants is led by a trial-and-error approach. The prescribing of these medications is complicated by sub-optimal efficacy and high rates of adverse drug reactions (ADRs). Read more

Formulation of heterogenous solid dispersions produced by spray drying and hot-melt extrusion for improved delivery of amorphous drugs

  Research Group: Pharmacology and Experimental Therapeutics
Production of the amorphous solid dispersions (ASDs) is a one of the methods of improving of physicochemical properties of an active pharmaceutical ingredient (API) such as its solubility and physicochemical stability. Read more

Formulation and biopharmaceutical characterisation of novel pro-antibiotics for improved oral permeability

  Research Group: Medicines Development and Pharmaceutical Sciences
This project is focused on the formulation, synthesis, and biopharmaceutical characterisation of novel pro-antibiotics for improved oral bioavailability. Read more

Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer

  Research Group: Institute of Cancer Therapeutics
Despite treatment advances, one of the most common cancers, colorectal cancer (CRC), still has a 45% mortality rate, and one of the major problems is the build-up of resistance to cancer drugs during treatment (‘acquired resistance’) such that over time the drugs stop working. Read more

Development of Naked Mole Rat Colonic Crypt Models to Use in the Search for Bowel Disease Preventatives

  Research Group: Institute of Cancer Therapeutics
Diseases affecting the bowel such as colorectal cancer (CRC) and the inflammatory bowel diseases (IBD) ulcerative colitis and Crohn’s disease are major global healthcare challenges in the 21st century. Read more

Design, synthesis and evaluation of protease-activated anti-cancer prodrugs

  Research Group: Institute of Cancer Therapeutics
Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis. Read more

Filtering Results